• Study Comparing MK-7684A (Vibostolimab and Pembrolizumab) with Pembrolizumab for Adults and Children with High-Risk Stage II-IV Melanoma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium France Germany Ireland Italy +3
  • Study on the Safety and Effects of BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia

    Not recruiting

    2 1 1
    Investigated diseases:
    Belgium Czechia Denmark Finland France Germany +5
  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Investigated drugs:
    Bulgaria Czechia Denmark France Portugal Slovakia
  • Study on the Effectiveness of Vidofludimus Calcium (IMU-838) in Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Germany Lithuania Poland
  • Evaluation of the Drug‑Drug Interaction Between Ramipril and Indapamide in Healthy Volunteers

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia
  • Comparative Bioavailability of Inhaled Levodopa (Levodopa Cyclops) versus Inhaled Levodopa Powder with Carbidopa in Healthy Adults for Parkinson’s Disease

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria
  • Study of BI 1810631 (C‑14) oral solution, BI 1810631 (C‑14) IV microtracer, and BI 1810631 tablet to assess absorption and metabolism in healthy men

    Not recruiting

    1 1 1
    Investigated drugs:
    The Netherlands
  • Safety and Tolerability of Topical Iodine (DLQ03) in Patients with Mild to Moderate Atopic Dermatitis Colonized with Staphylococcus aureus

    Not recruiting

    2 1 1
    Investigated diseases:
    The Netherlands
  • Bioequivalence study of ezetimibe and atorvastatin tablets versus film‑coated tablets in healthy volunteers

    Not recruiting

    1 1 1 1
    Spain
  • Multiple Ascending Dose Safety, Tolerability and Pharmacokinetics of MK-7602 in Healthy Volunteers for Malaria

    Not recruiting

    1 1
    Belgium

powered by